Status:
COMPLETED
Conjugated Linoleic Acid (1:1 Isomer Mixture) Intake in Overweight People
Lead Sponsor:
Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
Conditions:
Overweight
Obesity
Eligibility:
All Genders
30-55 years
Phase:
PHASE4
Brief Summary
The aim of the study was to examine the effects and safety of 3 g of a 1:1 mix of c9-t11 and t10-c12 (Tonalin®) on weight control and body composition in healthy overweight individuals who maintained ...
Eligibility Criteria
Inclusion
- aged 30-55 years
- grade II overweight (BMI≥27 but \<30 kg/m2)
- not to be adhered to any calorie restriction diet
- not to be taking any weight control medication or have lost more than 5 kg in the three months prior to the study
Exclusion
- suffering of serious concomitant disease such as diabetes mellitus type II, metabolic syndrome (according to the criteria of the Adult Treatment Panel III), cancer, kidney disease, HIV, tuberculosis, cardiovascular disease, chronic obstructive pulmonary disease, eating disorders.
- having undergone bariatric surgery and/or intestinal resection
- breastfeeding and pregnancy.
- not to give their signed, informed consent to be included in the study.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01503047
Start Date
March 1 2008
Last Update
January 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario La Paz
Madrid, Madrid, Spain, 28046